ClinicalTrials.gg
RecruitingNCT07285915CortizolUpdated May 1, 2026

The Role of Stress in Cardiac Arrest (Cortizol CPR)

An interventional study of Sample of hair in Chronic Stress, Cardiac Arrest (CA) and Post-Resuscitation Syndrome, sponsored by University Hospital Pilsen. Recruiting at 1 site in Czechia. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-05-01.

Sponsored by University Hospital Pilsen · Not applicable, Interventional, and Screening

How we know

From the registry’s dates

  • Started Jan 2026; still recruiting 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
136
Allocation
Non-randomized
Ages
18 Years to 100 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Heart Arrest with a site in Czechia — 7 open to participants now, 8 under way, none of them phase 3. Heart Arrest · Czechia.

Started
2026
with 2 others
No phase
8 of 15
4 open now
Registered
13th of 15
by date
Lead sponsor
2 of 15
University Hospital Pilsen

Among the 15 studies in Heart Arrest with a site in Czechia, this one is one of 3 that started in 2026, is one of 8 with no phase, and was the 13th registered.

Heart Arrest

927 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.

Browse Heart Arrest studies →

Open to participants now

7 of the 15 studies in Heart Arrest with a site in Czechia are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Czechia have not opened yet or have stopped. Only those recruiting at a site in Czechia →

Who these studies take

Of the 157 Heart Arrest studies recruiting now, 109 (69%) set no upper age limit and 28 (18%) stop at 75 or younger; 30 take children under 18; 18 take healthy volunteers.

This study: 18 Years to 100 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Heart Arrest with a site in Czechia, or all of them as a file.
02

Study summary

The aim of this study is to assess long-term stress in patients after an out-of-hospital cardiac arrest. To do this, we will measure levels of the stress hormone cortisol in hair samples. Cortisol is produced in larger amounts during periods of ongoing stress and builds up in the hair as it grows. Because hair grows about 1 cm per month, a 3 cm hair sample can show your average stress level over the past three months. The results will be compared with anonymized information from your medical records and the care you received before and during your hospital stay.

Read the detailed description

Despite significant advances in resuscitation medicine, out-of-hospital cardiac arrest (OHCA) continues to carry a poor prognosis, with survival accompanied by good neurological outcomes in only about 30% of cases. In Europe, OHCA affects approximately 67-170 individuals per 100,000 annually; in the Czech Republic, the incidence is around 90 per 100,000. Most cardiac arrests (60-70%) are of cardiovascular origin, where long-term stress is a known contributing risk factor.

Chronic stress not only influences the development of cardiovascular disease but also affects its clinical manifestation by modulating the autonomic nervous system-an essential regulator of heart rhythm and arrhythmogenic risk. Therefore, it is plausible that prolonged stress also contributes to the onset and course of cardiac arrest.

While the relationship between chronic stress and cardiovascular disease has been well documented, data specifically linking stress to out-of-hospital cardiac arrest are still lacking. The pathophysiological factors influencing the onset and refractoriness of OHCA also remain unclear.

This study aims to evaluate chronic stress levels in patients after OHCA by measuring cortisol concentrations in hair samples. Since cortisol accumulates in hair during its growth, a 3 cm segment reflects stress exposure over the previous three months. These findings will be correlated with patients' demographic and clinical profiles, including post-resuscitation condition severity, neurological outcomes, and potential arrest refractoriness.

03

Conditions studied

  • Chronic Stress
  • Cardiac Arrest (CA)
  • Post-Resuscitation Syndrome
  • Heart Attack

Keywords

  • cardiac arrest
  • chronic stress
  • kortizol
  • hair
04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Cardiac arrest
  • Heart attack
  • 18 - 100 years

Exclusion criteria

Exclusion Criteria:

  • Disapproval patient´s relatives with the study
  • Chronical treatment with corticoids and antidepresives
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
136 participants (estimated)

Study arms

  • Experimental
    Cardiac arrest

    Cardiac arrest

    Diagnostic Test: Sample of hair

  • Experimental
    Heart attack

    Heart attack

    Diagnostic Test: Sample of hair

Interventions

  • Diagnostic testSample of hair

    Sampling of 3cm of hair due to level of cortizol.

06

What researchers measure

Primary outcomes

  1. Hair cortisol levels assessment in CA patients vs heart attack patients

    Hair cortisol levels assessment in CA patients vs heart attack patients

    Time frame: Enrollment

Secondary outcomes

  1. Correlation of neurological outcomes using the CPC scale in CA patients with hair cortisol levels.

    Correlation of neurological outcomes using the CPC scale in CA patients with hair cortisol levels.

    Time frame: 30 and 90 days after CA

  2. Correlation between the severity of the post-resuscitation course according to the severity of organ damage (heart, lung, kidneys, brain ) and hair cortisol levels

    Correlation between the severity of the post-resuscitation course according to the severity of organ damage (heart, lung, kidneys, brain ) and hair cortisol levels

    Time frame: 30 days after CA

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Jul 2027, 18 months after the start.

Of 205 non-industry interventional studies with no phase under Heart Arrest, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 47. This study's planned 18 months is below that.

Counting every sponsor, half of 219 studies reached it within 28 months; a quarter within 10 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 18, 2025
First posted
Dec 16, 2025
StartActual
Jan 8, 2026
Primary completionEst.
Jul 31, 2027
CompletionEst.
Oct 31, 2027
Last update
May 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07285915
Lead sponsor
University Hospital Pilsen
Responsible party
Sponsor
First posted
Dec 16, 2025
Start date
Jan 8, 2026
Primary completion
Jul 31, 2027 (estimated)
Completion
Oct 31, 2027 (estimated)
Last update
May 1, 2026

Study contacts

Jana Smalcova, MD, Ph.D.
Contact
jana.smalcova@gmail.com
775 360 017 ext. +420
Milan Hromadka, MD, Ph.D.
Contact
hromadka@fnplzen.cz
377 105 840 ext. +420

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion